Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06588998
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-05
Brief Title:
Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implant Soft Tissue Dehiscences A Randomized Controlled Clinical Trial
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implant Soft Tissue Dehiscences A Randomized Controlled Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Peri-implant soft tissue dehiscences represent a common complication in implant dentistry often leading to esthetic and functional challenges Current treatment options including Xengenic cortical membranes and connective tissue graft with coronally advanced flap aim to promote soft tissue regeneration and improve clinical outcomes However there is a need for comparative studies to determine the optimal treatment modality for peri-implant soft tissue dehiscences
Detailed Description:
Aim Comparing the effectiveness and patient outcomes of Xengenic cortical membranes versus connective tissue graft with coronally advanced flap for the treatment of peri-implant soft tissue dehiscences
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None